Corporate Overview

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription products.

Read more

Why Invest


Diversified Pipeline Candidates


Invested by Founders


Worldwide Sales Potential of Mino-Lok®


Inflection Point for Value Driving Catalysts

Learn more

Latest News

View all news

Latest Presentation

Latest Events

View All Events

Latest Financial Reports

View All Financial Reports